about
The structure of the human gene encoding protein gene product 9.5 (PGP9.5), a neuron-specific ubiquitin C-terminal hydrolaseVasitis nodosa and associated clinical findings.Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and updatePGP 9.5 immunocytochemical staining for pancreatic endocrine tumorsCarcinoid tumour of stomach and primary hyperparathyroidism: a new association.Some aspects of neuroendocrine pathology.Comparison of immunological detection of 5-hydroxytryptamine by monoclonal antibodies with standard silver stains as an aid to diagnosing carcinoid tumours.The innervation of the human myocardium at birth.The neurochemical maturation of the rabbit cerebellum.Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the ratPernicious anaemia and mucosal endocrine cell proliferation of the non-antral stomachMolecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells.Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.Neuronal protein gene product 9.5 (IEF SSP 6104) is expressed in cultured human MRC-5 fibroblasts of normal origin and is strongly down-regulated in their SV40 transformed counterparts.Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.Immunocytochemical patterns of islet cell tumors as defined by the monoclonal antibody HISL-19.Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies.Granular cell tumour of the common bile duct.Small bowel infarction associated with pancreatic glucagonoma.Emerging roles of deubiquitinating enzymes in human cancer.An intrinsic adrenergic system in mammalian heart.Deubiquitinases and the new therapeutic opportunities offered to cancer.Expression of epithelial membrane antigen by carcinoid tumours.An intrinsic cardiac adrenergic system can regulate cardiac development and function.A pulmonary large cell carcinoma cell line expressing neuroendocrine cell markers and human chorionic gonadotropin alpha-subunit.Paraganglioma of the cauda equinaImmunohistochemical localization of protein gene product 9.5, ubiquitin, and neuropeptide Y immunoreactivities in epithelial and neuroendocrine cells from normal and hyperplastic human prostate.Atrial myxoma: a tumour in search of its origins.Cerebellar cortical degeneration in association with small-cell carcinoma of the oesophagus.Presence of neuroendocrine cells during postnatal development in rat prostate: Immunohistochemical, molecular, and quantitative study.Rho-kinase expression in Hirschsprung's disease.Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung.
P2860
Q24527361-CC4BF060-2B4A-48D9-B401-5914F27BAFABQ24529095-43284480-76BC-4EB1-9F4E-F1913CEADBC7Q24655587-96B6470A-7FCF-46D6-B7FA-7EC494DB73F6Q33728081-AFD9518C-C74F-444D-ADB0-9D1AB29B9CEEQ33837894-DD633126-5575-4FFD-B1D5-D38C0A20AFA0Q33838204-E06F710E-EEC7-42E5-A226-4D9E447992B9Q33838905-5EA923CD-BAB7-4569-810F-FBEB930A413AQ33881087-94931B62-FDB2-4DB5-8780-A08F445C212BQ33881528-E09F2E27-7378-4C32-B4B6-8DA6521C90F3Q34104412-E4998436-5B4C-46E3-990E-FD819155C916Q34528278-DAD254C9-B88B-4F73-A14D-7C74E6C30B89Q34529829-DFF9662B-777C-49AF-9399-2D701F8219F8Q34562649-25BAF707-A689-4790-ABBE-BC22CBAC71B8Q34747216-90EF830B-15B1-4EB9-BF26-C3075D167F7DQ34780208-F6E8D27A-06AA-4B9D-BF2C-B85905A8854AQ35719602-BEE74325-A67F-469C-BC26-83BE31EDE61BQ35818875-C9462E08-13CC-4682-B353-AC46C620F390Q35993383-DFF3F838-9F5B-4A55-B36C-998EF328B7B7Q36051175-0EA80465-C5F3-4E6F-AF06-8A764D878D7FQ36707724-AA68E5A3-C389-40AE-94F4-F5922F63022BQ36723955-4609AA13-CF2A-4AC5-90B6-3FC55D3B6BC0Q36920753-A7F063D0-F813-4E32-B5A8-7CC7DD31BA06Q37359612-4FE6C3B9-9FAA-4F51-AAFD-E49356D05C8EQ38326071-9A9F3BA9-D48D-400A-89DF-5C3803BD4E3DQ39649374-3E38D16D-B2F8-4547-B4B3-A1D6D9CA77BAQ39770580-F62F482D-768D-4585-80B3-51E64D7EBD9DQ41706833-760E9F94-9A0F-4700-B321-24A767F43EFCQ42078842-6035EB60-2CD7-4829-A5E7-026FFEF2E4B6Q42490746-6E74E5CF-4B81-4BC7-A47D-A0B6C0FEB89EQ42577392-072DFA44-7EB3-4A34-9435-CD538CCAAA59Q44208578-37B8599F-FC17-45DD-8B45-28FE8C800B40Q44569680-49B36113-AF45-4557-B5C0-01AB7C2C7F7CQ48146127-6465F63A-771D-4880-ADB3-F682D1891215Q52238510-F5D1B6D6-9AC9-4E55-AA3F-FFF9C5F7D94E
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
PGP 9.5, a new marker for human neuroendocrine tumours.
@en
PGP 9.5, a new marker for human neuroendocrine tumours.
@nl
type
label
PGP 9.5, a new marker for human neuroendocrine tumours.
@en
PGP 9.5, a new marker for human neuroendocrine tumours.
@nl
prefLabel
PGP 9.5, a new marker for human neuroendocrine tumours.
@en
PGP 9.5, a new marker for human neuroendocrine tumours.
@nl
P2093
P2860
P1433
P1476
PGP 9.5, a new marker for human neuroendocrine tumours.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.1985.TB02431.X
P577
1985-02-01T00:00:00Z